| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:1319015 | 6480464 | epigallocatechin gallate results in increased expression of RGL1 mRNA | CTD | PMID:22079256 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1319015 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RGL1 mRNA | CTD | PMID:22079256 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of RGL1 mRNA]; more ... | CTD | PMID:19414516 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1319016 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RGL1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1319015 | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of RGL1 mRNA | CTD | PMID:20404318 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1319015 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RGL1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1319016 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RGL1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1319015 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RGL1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1319016 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RGL1 mRNA | CTD | PMID:17942748 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of RGL1 mRNA | CTD | PMID:21346803 |
| 3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of RGL1 mRNA] | CTD | PMID:19414516 |
| benzo[a]pyrene | increases expression | ISO | RGD:1319016 | 6480464 | Benzo(a)pyrene results in increased expression of RGL1 mRNA | CTD | PMID:20713471 |
| benzo[a]pyrene | increases expression | ISO | RGD:1319016 | 6480464 | Benzo(a)pyrene results in increased expression of RGL1 mRNA | CTD | PMID:20713471 PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:1319015 | 6480464 | Benzo(a)pyrene results in increased expression of RGL1 mRNA | CTD | PMID:21632981 |
| benzo[a]pyrene | affects expression | ISO | RGD:1319016 | 6480464 | Benzo(a)pyrene affects the expression of RGL1 mRNA | CTD | PMID:22342234 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1319015 | 6480464 | Benzo(a)pyrene results in decreased expression of RGL1 mRNA | CTD | PMID:20064835 |
| copper(2+) sulfate | increases expression | ISO | RGD:1319015 | 6480464 | Copper Sulfate results in increased expression of RGL1 mRNA | CTD | PMID:19549813 |
| cytarabine | decreases expression | ISO | RGD:1319015 | 6480464 | Cytarabine results in decreased expression of RGL1 mRNA | CTD | PMID:21198554 |
| diarsenic trioxide | increases expression | ISO | RGD:1319015 | 6480464 | arsenic trioxide results in increased expression of RGL1 mRNA | CTD | PMID:19128835 |
| doxorubicin | decreases expression | ISO | RGD:1319016 | 6480464 | Doxorubicin results in decreased expression of RGL1 mRNA | CTD | PMID:19277126 |
| hydrogen peroxide | affects expression | ISO | RGD:1319015 | 6480464 | Hydrogen Peroxide affects the expression of RGL1 mRNA | CTD | PMID:20044591 |
| hypochlorous acid | decreases expression | ISO | RGD:1319016 | 6480464 | Hypochlorous Acid results in decreased expression of RGL1 mRNA | CTD | PMID:19376150 |
| melphalan | decreases expression | ISO | RGD:1319015 | 6480464 | Melphalan results in decreased expression of RGL1 mRNA | CTD | PMID:22363485 |
| menadione | affects expression | ISO | RGD:1319015 | 6480464 | Vitamin K 3 affects the expression of RGL1 mRNA | CTD | PMID:20044591 |
| paracetamol | affects expression | ISO | RGD:1319016 | 6480464 | Acetaminophen affects the expression of RGL1 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:1319015 | 6480464 | Acetaminophen results in decreased expression of RGL1 mRNA | CTD | PMID:21420995 |
| pirinixic acid | multiple interactions | ISO | RGD:1319015 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RGL1 mRNA | CTD | PMID:19710929 |
| quercetin | increases expression | ISO | RGD:1319015 | 6480464 | Quercetin results in increased expression of RGL1 mRNA | CTD | PMID:21632981 |
| raloxifene | multiple interactions | ISO | RGD:1319015 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in decreased expression of RGL1 mRNA | CTD | PMID:19059307 |
| tamoxifen | multiple interactions | ISO | RGD:1319015 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of RGL1 mRNA | CTD | PMID:19059307 |